Back to Results
First PageMeta Content
Biology / Vi capsular polysaccharide vaccine / Typhoid fever / Meningococcal vaccine / Vaccination schedule / Vaccination / Typhoid vaccine / NmVac4-A/C/Y/W-135 / Influenza vaccine / Vaccines / Medicine / Health


Sanofi Pasteur 093 Typhim Vi® 1 March 2014, v0.3
Add to Reading List

Open Document

File Size: 253,45 KB

Share Result on Facebook

City

Katmandu / /

Company

CI GROUP / Sanofi Pasteur SA / /

Continent

Asia / Africa / /

Country

Indonesia / Nepal / United States / South Africa / /

Event

FDA Phase / Product Issues / /

IndustryTerm

chronic carrier state / foreign travel / contaminated food / documented typhoid carrier / colorless solution / food handlers / control / sterile solution / food / /

MedicalCondition

headaches / bacteremia / disease / acute typhoid fever / agammaglobulinemia / typhoid fever / documented typhoid carrier / chronic carrier state / enteric disease / fever / Typhoid / systemic illness / intestinal perforation / Allergic reactions / hypogammaglobulinemia / diarrhea / Infection / Constipation / infections / infectious disease / immunodeficiency disease / /

MedicalTreatment

immunization / immunosuppressive therapy / active immunization / vaccination / /

MusicAlbum

Africa / Asia / South America / Central / /

Organization

Concomitant Administration of Typhim Vi and Menactra / Centers for Disease Control and Prevention / /

/

Product

Sodium Chloride / Sterile Water for Injection / Typhim Vi vaccine / water / food / /

Region

South America / Central America / /

Technology

antibodies / /

SocialTag